Trials / Completed
CompletedNCT02485093
To Pace or Not to Pace in Sinus Node Disease
Comparison of Ventricular Septal Pacing With Optimized Atrioventricular (AV) Delay to no Pacing in Sinus Node Disease (SND) Patients.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 215 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Optimal pacing strategy for patients with SND is still unknown, although several publications in the past years demonstrated a deleterious effect of ventricular pacing. However, pacing has always been apical in these trials, and to which extent this absence of pacing is beneficial for patients with very long PR intervals is still to be found. The aim of this study is to compare ventricular septal pacing to no pacing in patients with SND.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Septal ventricular pacing | Ventricular pacing must be at least 90%, from the septum and with optimized AV delay |
| DEVICE | VIP | Ventricular pacing must be less than 10%. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2013-07-01
- Completion
- 2014-10-01
- First posted
- 2015-06-30
- Last updated
- 2019-02-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02485093. Inclusion in this directory is not an endorsement.